// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Bronchiolitis prevalence rates in Congenital Diaphragmatic Hernia: a systematic review and meta-analysis

Leonie Lewis - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital diaphragmatic hernia

Palivizumab

Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection?

Gemma Wilson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Palivizumab

Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)

Naomi Parsons - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

N/A

Pseudomonas aeruginosa isolation in respiratory samples of children with neurological impairment- does it matter?

Katie Wilkinson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Colistimethate sodium

Severity Scores used in the assessment of Bronchiolitis: A systematic review

William Bedson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Response of the paediatric Long Term Ventilation (LTV) department of Cambridge University Hospital (CUH) during the Covid-19 pandemic: challenges and lessons

Lucy Carson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Parental perceptions of home Cardio respiratory sleep studies for children during Covid-19 pandemic

Omendra Narayan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of outpatient rehabilitation programme on physical fitness for patients post covid-19

Thomas Williamson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Is Pulmonary Rehabilitation (PR) effective in people recovering from severe COVID-19 (C-19) pneumonia?

Francesca Knight - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Does virtual breathing pattern retraining improve breathlessness in patients with post COVID syndrome?

Lauren Williamson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Outcomes of physiotherapy management in children and young people (CYP) with breathing pattern disorders (BPD)

Naomi Parsons - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hold your breath again: Exploring dysfunctional breathing assessments in healthy individuals

Laís Vidotto - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Airway clearance practice in people with bronchiectasis: A Northern Ireland (NI) survey

Katherine O’Neill - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical effectiveness of Tele-Pulmonary rehabilitation: a comparative study to face to face pulmonary rehabilitation

Kola Akinlabi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Video based telerehabilitation: patient acceptability and experience in chronic respiratory disease

Ken Johnston - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of a physiotherapist-led remote breathlessness clinic for community lung patients: the Respiratory Advice and Management Physiotherapy (RAMP) service

Emily Johnstone - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Phenotypic features of bullying induced dyspnoea in children

Claire Hepworth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How successful are medical thoracoscopists at predicting non-expandable lung?

Syed Ajmal - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Are people with mesothelioma well represented in the English cancer patient experience survey?

Yvonne Nartey - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Variation in outcomes for M1a Stage Lung cacers- Outcome in Malingnat Pleural Effusion significantly worse than patients with Contralateral Lung Nodules

Sayed Alderazi - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

Roxithromycin

Copyright © 2026. QuantiNova All rights reserved